Atugen Raises 5M for Developing siRNA Therapeutics

genomeweb
360dx

Atugen Raises 5M for Developing siRNA Therapeutics

Mar 15, 2004

NEW YORK, March 15 (GenomeWeb News) - RNAi firm Atugen has raised €5 million in a third financing round, the company said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Natera, Neon Therapeutics Ink Research Partnership for Personalized Cancer Vaccines
Mount Sinai Researchers Develop Protein Barcoding Technology for Single-Cell CRISPR Screening
Broad Institute Launches Patient-Partnered Cancer Research Non-Profit Organization
Protagen, NCT Heidelberg Partner to Predict Immunotherapy Response in Urothelial Cancer
Molecular Loop Acquires Inversion Probe Tech From Invitae
Fabric Genomics, Genomenon Sign Comarketing Deal

The Scan

Breakthrough Prize Winners Announced

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

Misuse of Genetic Research

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Not Quite the Ivy League Gene

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

This Week in Nature

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Main menu